[Event Report] The Third Advisory Board Meeting for the Immunization and Vaccination Policy Promotion Project, “Data Collection and Application to Appropriately Evaluate Vaccination Outcomes” (November 10, 2020)
date : 12/1/2020
Tags: Vaccinations
Health and Global Policy Institute (HGPI) held the third advisory board meeting for the Immunization and Vaccination Policy Promotion Project, entitled “Data Collection and Application to Appropriately Evaluate Vaccination Outcomes .”
Following the discussion at the first meeting, the discussion held at the third advisory board meeting focused on issues encountered during the three stages of data collection, data comparison and sharing when using multiple databases, and evaluating collected data when using databases containing information related to vaccine coverage, the survey system on infectious diseases, and reports of adverse vaccine reactions.
Various points that will need to be considered to achieve a life-course approach were raised during the discussion. These included the significance of clearly demonstrating vaccine effects by developing databases; the future possibilities of information disclosure, related personal information protection, and their legal provisions; and the current situation surrounding the digitization of vaccine records by the Japanese Government as well as its relation to the vaccine surveillance system.
Due to the circumstances regarding the COVID-19 pandemic, this meeting was held online.
■Overview
Date & Time: Tuesday, September 15, 2020
Organizer: Health and Global Policy Institute
■Advisory Board Members and Observers (alphabetical order by last name)
Members:
- Kyoko Ama (Former Representative, Ippan Shadan Hojin Shiro Shoni Iryo Mamoro Kodomo-tachi no Kai)
- Hidenori Arai (President, National Center for Geriatrics and Gerontology; Vice President, The Japan Geriatrics Society)
- Satoshi Iwata (Department of Infectious Diseases, National Cancer Center Hospital)
- Isao Miyairi (Medical Director, Department of Infectious Diseases, National Center for Child Health and Development)
- Kuniko Nakayama (Director, My Family Clinic Gamagori, Medical Association Mefa Jinaikai)
- Akihiko Saitoh (Professor, Department of Pediatrics, Graduate School of Medical and Dental Sciences, Niigata University)
- Akinori Sugaya (Head Physician, Sugaya Children’s Clinic; Director, KNOW VPD Protect Our Children)
- Mugen Ujiie (Director of Travel Clinic, Director of Immunization Support Center, Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine (NCGM))
Observers:
- Masayuki Imagawa (Representative Director, Japan Vaccine Industry Association (President))
- Naoki Karayama (Senior Expert, Public Relations Division, GlaxoSmithKline K.K.)
- Shiori Masuda (Chief, Vaccine Market Access Division, GlaxoSmithKline K.K.)
- Yukiko Nakatani (Director, Blood and Blood Products Division, Pharmaceutical Safety and Environmental Health Bureau, MHLW)
- Leon Ochiai (Head, Public Relations Division, Responsible for Vaccine, Sanofi K.K.)
- Naokazu Saito (Director, Policy Intelligence Department, Janssen Pharmaceutical K.K.)
- Daisaku Sato (Chief Management Officer & Associate Centre Director for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Japan)
Moderator:
- Ryoji Noritake (CEO, Board Member, HGPI)
MC:
- Joji Sugawara (Senior Associate, HGPI)
Secretariat:
- Yui Kohno (Associate, HGPI)
- Yuka Nakamura (Intern, HGPI)
- Ryuta Saito (Assistant, HGPI)
■Related contents held as part of the project (chronological order)
– September 7, 2020 [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)